Cranbury, NJ, United States of America

Mukteeshwar Gande

This inventor holds 1 USPTO granted patent. Top assignee: Invamed, Inc.. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mukteeshwar Gande. Retrieved from https://idiyas.com/inventor/mukteeshwar-gande

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mukteeshwar Gande: Innovator in Pharmaceutical Composition

Introduction

Mukteeshwar Gande is a notable inventor based in Cranbury, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on ticlopidine hydrochloride.

Latest Patents

Gande holds a patent for a stabilized composition of ticlopidine hydrochloride. This novel pharmaceutical composition includes thieno-pyridine derivatives, primarily ticlopidine hydrochloride, without any other organic or inorganic acid stabilizing agents or metal stearates. The stable pharmaceutical composition also incorporates hydrogenated vegetable oil as a lubricant and other suitable non-ionic inert pharmaceutical excipients.

Career Highlights

Gande is currently employed at Invamed, Inc., where he continues to develop and refine pharmaceutical compositions. His work has been instrumental in advancing the stability and efficacy of important medications.

Collaborations

One of his notable coworkers is Pankaj J. Dave, with whom he collaborates on various projects within the pharmaceutical sector.

Conclusion

Mukteeshwar Gande's innovative contributions to pharmaceutical compositions highlight his expertise and commitment to improving medication stability and effectiveness. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…